Reform history

Commission Implementing Regulation (EU) 2026/312 of 10 February 2026 renewing the approval of the active substance maltodextrin as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011